NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
2.360
-0.080 (-3.28%)
At close: Dec 5, 2025, 4:00 PM EST
2.358
-0.002 (-0.07%)
After-hours: Dec 5, 2025, 7:51 PM EST
NRx Pharmaceuticals Market Cap
NRx Pharmaceuticals has a market cap or net worth of $66.31 million as of December 5, 2025. Its market cap has increased by 322.36% in one year.
Market Cap
66.31M
Enterprise Value
69.38M
1-Year Change
322.36%
Ranking
Category
Stock Price
$2.36
Market Cap Chart
Since November 20, 2017, NRx Pharmaceuticals's market cap has increased from $65.80M to $66.31M, an increase of 0.78%. That is a compound annual growth rate of 0.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 68.60M | 157.89% |
| Dec 31, 2024 | 26.60M | -31.09% |
| Dec 29, 2023 | 38.60M | -48.60% |
| Dec 30, 2022 | 75.10M | -73.28% |
| Dec 31, 2021 | 281.10M | 328.51% |
| Dec 31, 2020 | 65.60M | 2.02% |
| Dec 31, 2019 | 64.30M | -30.26% |
| Dec 31, 2018 | 92.20M | 44.97% |
| Dec 29, 2017 | 63.60M | -3.34% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 923.82B |
| Johnson & Johnson | 495.64B |
| AbbVie | 406.76B |
| UnitedHealth Group | 307.66B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 254.72B |
| Thermo Fisher Scientific | 218.96B |